About this file

This is an amendment to an FDA Request for Quote (RFQ) issued under Solicitation No. 75F40126133227. Amendment No. 01, dated April 8, 2026, corrects errors in the Period of Performance for three line items (Line Items 1, 2, and 3) on page 1 of the original solicitation. The specific revised performance periods are not detailed in this amendment document itself; rather, offerors are instructed to reference the attached amended PDF file titled "Amended (0001)_FDA_RFQ_75F40126133227" for the corrected line item details and performance period dates. Offerors must respond only to the amended RFQ document and incorporate all changes reflected in this amendment into their proposals.

View the file

Other files

File Type Posted
Amended (0001)_FDA_RFQ_75F40126133227.pdf PDF
FDA RFQ_75F40126Q133227.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FDA Solicitation No.: 75F40126133227 Amendment No.: 01 Date: April 8, 2026

The purpose of this amendment is as follows:

1. Correct an error in Period of Performance on Line Item 1 (page 1);

2. Correct an error in Period of Performance on Line Item 2 (page 1);

3. Correct an error in Period of Performance on Line Item 3 (page 1).

New text is underlined. Revised text is in boldface font. Deleted text is in strike-through.

Offerors shall respond only to the attached PDF file titled Amended

(0001)_FDA_RFQ_75F40126133227.

END OF AMENDMENT NO.: 0001

File details come from the government source that posted it. Updated .